BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kageyama Y, Nishizaki Y, Aida K, Yayama K, Ebisui T, Akiyama T, Nakamura T. Lactobacillus plantarum induces innate cytokine responses that potentially provide a protective benefit against COVID-19: A single-arm, double-blind, prospective trial combined with an in vitro cytokine response assay. Exp Ther Med 2022;23:20. [PMID: 34815772 DOI: 10.3892/etm.2021.10942] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Lai CKC, Cheung MK, Lui GCY, Ling L, Chan JYK, Ng RWY, Chan HC, Yeung ACM, Ho WCS, Boon SS, Chan PKS, Chen Z. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients. Microbiol Spectr 2022. [DOI: 10.1128/spectrum.02196-22] [Reference Citation Analysis]
2 Neris Almeida Viana S, do Reis Santos Pereira T, de Carvalho Alves J, Tianeze de Castro C, Santana C da Silva L, Henrique Sousa Pinheiro L, Nougalli Roselino M. Benefits of probiotic use on COVID-19: A systematic review and meta-analysis. Crit Rev Food Sci Nutr 2022;:1-13. [PMID: 36178362 DOI: 10.1080/10408398.2022.2128713] [Reference Citation Analysis]
3 Idrees M, Imran M, Atiq N, Zahra R, Abid R, Alreshidi M, Roberts T, Abdelgadir A, Tipu MK, Farid A, Olawale OA, Ghazanfar S. Probiotics, their action modality and the use of multi-omics in metamorphosis of commensal microbiota into target-based probiotics. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.959941] [Reference Citation Analysis]
4 Rocchi G, Giovanetti M, Benedetti F, Borsetti A, Ceccarelli G, Zella D, Altomare A, Ciccozzi M, Guarino MPL. Gut Microbiota and COVID-19: Potential Implications for Disease Severity. Pathogens 2022;11:1050. [DOI: 10.3390/pathogens11091050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Synodinou KD, Nikolaki MD, Triantafyllou K, Kasti AN. Immunomodulatory Effects of Probiotics on COVID-19 Infection by Targeting the Gut–Lung Axis Microbial Cross-Talk. Microorganisms 2022;10:1764. [DOI: 10.3390/microorganisms10091764] [Reference Citation Analysis]
6 Wahab S, Almaghaslah D, Mahmood SE, Ahmad MF, Alsayegh AA, Abu Haddash YM, Rahman MA, Ahamd I, Ahmad W, Khalid M, Usmani S, Ahmad MP, Hani U. Pharmacological Efficacy of Probiotics in Respiratory Viral Infections: A Comprehensive Review. JPM 2022;12:1292. [DOI: 10.3390/jpm12081292] [Reference Citation Analysis]
7 Sapra L, Saini C, Garg B, Gupta R, Verma B, Mishra PK, Srivastava RK. Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics. Inflamm Res 2022. [PMID: 35900380 DOI: 10.1007/s00011-022-01616-9] [Reference Citation Analysis]
8 Liu S, Zhao Y, Feng X, Xu H. SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies. Crit Rev Food Sci Nutr 2022;:1-19. [PMID: 35894645 DOI: 10.1080/10408398.2022.2103090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Trukhan DI. Disorders of intestinal microbiocenosis: expanding the application of probiotics. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-7-132-143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]